These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG. Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318 [TBL] [Abstract][Full Text] [Related]
43. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae]. Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791 [TBL] [Abstract][Full Text] [Related]
44. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Coughlin RT; White AC; Anderson CA; Carlone GM; Klein DL; Treanor J Vaccine; 1998 Nov; 16(18):1761-7. PubMed ID: 9778753 [TBL] [Abstract][Full Text] [Related]
45. Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay. Barrett DJ; Ammann AJ; Stenmark S; Wara DW Infect Immun; 1980 Feb; 27(2):411-7. PubMed ID: 7380537 [TBL] [Abstract][Full Text] [Related]
46. Comparison of an enzyme-linked immunosorbent assay with radioimmunoassay for the measurement of pneumococcal capsular polysaccharide antibodies. Katz MA; Schiffman G Mol Immunol; 1985 Mar; 22(3):313-9. PubMed ID: 4000134 [TBL] [Abstract][Full Text] [Related]
47. Production and characterization of monoclonal antibodies specific for types 6 and 19 pneumococcal capsular polysaccharides. Milligan GN; Braley-Mullen H Mol Immunol; 1989 Sep; 26(9):799-807. PubMed ID: 2601723 [TBL] [Abstract][Full Text] [Related]
48. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide. van de Wiel PA; Witvliet MH; Evenberg D; Derks HJ; Beuvery EC Vaccine; 1987 Mar; 5(1):33-8. PubMed ID: 2437718 [TBL] [Abstract][Full Text] [Related]
49. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein. Beuvery EC; Roy R; Kanhai V; Jennings HJ Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115 [TBL] [Abstract][Full Text] [Related]
50. IgG and IgM pneumococcal polysaccharide antibody responses in infants. Barrett DJ; Lee CG; Ammann AJ; Ayoub EM Pediatr Res; 1984 Nov; 18(11):1067-71. PubMed ID: 6514433 [TBL] [Abstract][Full Text] [Related]
51. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371 [TBL] [Abstract][Full Text] [Related]
52. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine. Qiao W; Ji S; Zhao Y; Hu T Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319 [TBL] [Abstract][Full Text] [Related]
53. The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides. Jones HE; Taylor PR; McGreal E; Zamze S; Wong SY Vaccine; 2009 Sep; 27(42):5806-15. PubMed ID: 19660585 [TBL] [Abstract][Full Text] [Related]
54. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Michon F; Fusco PC; Minetti CA; Laude-Sharp M; Uitz C; Huang CH; D'Ambra AJ; Moore S; Remeta DP; Heron I; Blake MS Vaccine; 1998 Nov; 16(18):1732-41. PubMed ID: 9778749 [TBL] [Abstract][Full Text] [Related]
55. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272 [TBL] [Abstract][Full Text] [Related]
56. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide. Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714 [TBL] [Abstract][Full Text] [Related]
57. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice. Beuvery EC; van Delft RW; Miedema F; Kanhai V; Nagel J Infect Immun; 1983 Aug; 41(2):609-17. PubMed ID: 6409811 [TBL] [Abstract][Full Text] [Related]
58. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection. Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972 [TBL] [Abstract][Full Text] [Related]
59. Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier. Deauvieau F; Dussurgey S; Rossignol D; de Montfort A; Burdin N; Guy B Vaccine; 2009 Dec; 28(2):576-82. PubMed ID: 19878751 [TBL] [Abstract][Full Text] [Related]
60. Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive. Cohen N; Stolarsky-Bennun M; Amir-Kroll H; Margalit R; Nussbaum G; Cohen-Sfady M; Pevsner-Fischer M; Fridkin M; Bercovier H; Eisenbach L; Jung S; Cohen IR J Immunol; 2008 Feb; 180(4):2409-18. PubMed ID: 18250450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]